Brought to you by 
Ariad signs deforolimus-eluting stent deal with Icon Medical
12 Jun 2013
Executive Summary
Ariad Pharmaceuticals (cancer therapeutics) has signed a nonexclusive agreement with Icon Medical (cardiovascular devices) to develop and market drug-eluting stents to deliver Ariad's deforolimus.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Drug Delivery
-
Medical Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
-
Surgical Equipment & Devices
Deal Status
- Final
Deal Type
-
Alliance
- Includes Equity
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com